{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T17:57:04Z","timestamp":1793555824752,"version":"4.5.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10580-6","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:00:09Z","timestamp":1748430009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["An overview on cardiac regeneration revolution: exploring the promise of stem cell therapies"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3688-6443","authenticated-orcid":false,"given":"Parisa","family":"Noorabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5150-6018","authenticated-orcid":false,"given":"Venus","family":"Shahabi Rabori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6806-6327","authenticated-orcid":false,"given":"Sara","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6249-2587","authenticated-orcid":false,"given":"Negar","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6343-8518","authenticated-orcid":false,"given":"Mohammadreza","family":"Saberiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"10580_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.54393\/pbmj.v7i02.1034","volume":"7","author":"MM Hussain","year":"2024","unstructured":"Hussain MM et al (2024) Risk factors associated with cardiovascular disorders: risk factors associated with cardiovascular disorders. Pak BioMed J 7:3\u201310","journal-title":"Pak BioMed J"},{"issue":"1","key":"10580_CR2","doi-asserted-by":"crossref","first-page":"e35232","DOI":"10.34172\/jpe.2023.35232","volume":"9","author":"N Jafari","year":"2023","unstructured":"Jafari N et al (2023) How lifestyle factors can contribute to cardiovascular disease incidence; a review study. J Prevent Epidemiol 9(1):e35232\u2013e35232","journal-title":"J Prevent Epidemiol"},{"issue":"11","key":"10580_CR3","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.3390\/ijms25115772","volume":"25","author":"T Sugiura","year":"2024","unstructured":"Sugiura T, Shahannaz DC, Ferrell BE (2024) Current status of cardiac regenerative therapy using induced pluripotent stem cells. Int J Mol Sci 25(11):5772","journal-title":"Int J Mol Sci"},{"key":"10580_CR4","doi-asserted-by":"crossref","first-page":"1148618","DOI":"10.3389\/fcvm.2023.1148618","volume":"10","author":"U Chaudhari","year":"2023","unstructured":"Chaudhari U et al (2023) Genome-wide profiling of miRNA-gene regulatory networks in mouse postnatal heart development\u2014implications for cardiac regeneration. Front Cardiovasc Med 10:1148618","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10580_CR5","first-page":"185","volume":"74","author":"T Sano","year":"2020","unstructured":"Sano T et al (2020) Stem cell therapy in heart disease: limitations and future possibilities. Acta Med Okayama 74(3):185\u2013190","journal-title":"Acta Med Okayama"},{"issue":"10","key":"10580_CR6","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.7150\/thno.72289","volume":"12","author":"M Mongui\u00f3-Tortajada","year":"2022","unstructured":"Mongui\u00f3-Tortajada M et al (2022) Acellular cardiac scaffolds enriched with MSC-derived extracellular vesicles limit ventricular remodelling and exert local and systemic immunomodulation in a myocardial infarction porcine model. Theranostics 12(10):4656","journal-title":"Theranostics"},{"key":"10580_CR7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.biopha.2018.10.065","volume":"109","author":"R Rikhtegar","year":"2019","unstructured":"Rikhtegar R et al (2019) Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts. Biomed Pharmacother 109:304\u2013313","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"10580_CR8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41569-018-0013-0","volume":"15","author":"P Menasch\u00e9","year":"2018","unstructured":"Menasch\u00e9 P (2018) Cell therapy trials for heart regeneration\u2014lessons learned and future directions. Nat Rev Cardiol 15(11):659\u2013671","journal-title":"Nat Rev Cardiol"},{"key":"10580_CR9","first-page":"271","volume":"107","author":"JDS Rebou\u00e7as","year":"2016","unstructured":"Rebou\u00e7as JDS, Santos-Magalh\u00e3es NS, Formiga FR (2016) Cardiac regeneration using growth factors: advances and challenges. Arq Bras Cardiol 107:271\u2013275","journal-title":"Arq Bras Cardiol"},{"key":"10580_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/pm-22-17","volume":"6","author":"GS Brown","year":"2023","unstructured":"Brown GS, Jang J, Li D (2023) Growth factors and their roles in cardiac development and regeneration: a narrative review. Pediatric Med 6:1\u201311","journal-title":"Pediatric Med"},{"issue":"1","key":"10580_CR11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","volume":"7","author":"Q Zhang","year":"2022","unstructured":"Zhang Q et al (2022) Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther 7(1):78","journal-title":"Signal Transduct Target Ther"},{"issue":"24","key":"10580_CR12","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1101\/gad.1492806","volume":"20","author":"I Shiojima","year":"2006","unstructured":"Shiojima I, Walsh K (2006) Regulation of cardiac growth and coronary angiogenesis by the Akt\/PKB signaling pathway. Genes Dev 20(24):3347\u20133365","journal-title":"Genes Dev"},{"issue":"1","key":"10580_CR13","first-page":"18","volume":"10","author":"Q-Y Guo","year":"2023","unstructured":"Guo Q-Y et al (2023) Regeneration of the heart: from molecular mechanisms to clinical therapeutics. Mil Med Res 10(1):18","journal-title":"Mil Med Res"},{"key":"10580_CR14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fonc.2014.00384","volume":"4","author":"P Rizzo","year":"2015","unstructured":"Rizzo P et al (2015) The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors. Front Oncol 4:384","journal-title":"Front Oncol"},{"issue":"7","key":"10580_CR15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tcm.2011.11.006","volume":"20","author":"Y Li","year":"2010","unstructured":"Li Y, Hiroi Y, Liao JK (2010) Notch signaling as an important mediator of cardiac repair and regeneration after myocardial infarction. Trends Cardiovasc Med 20(7):228\u2013231","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"10580_CR16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIRCRESAHA.115.305350","volume":"118","author":"G Lux\u00e1n","year":"2016","unstructured":"Lux\u00e1n G et al (2016) Endocardial Notch signaling in cardiac development and disease. Circ Res 118(1):e1\u2013e18","journal-title":"Circ Res"},{"issue":"1","key":"10580_CR17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1083\/jcb.200806091","volume":"183","author":"C Collesi","year":"2008","unstructured":"Collesi C et al (2008) Notch1 signaling stimulates proliferation of immature cardiomyocytes. J Cell Biol 183(1):117\u2013128","journal-title":"J Cell Biol"},{"issue":"4","key":"10580_CR18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.yjmcc.2008.02.273","volume":"45","author":"M Nemir","year":"2008","unstructured":"Nemir M, Pedrazzini T (2008) Functional role of Notch signaling in the developing and postnatal heart. J Mol Cell Cardiol 45(4):495\u2013504","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10580_CR19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/01.CIR.104.3.330","volume":"104","author":"T Matsui","year":"2001","unstructured":"Matsui T et al (2001) Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104(3):330\u2013335","journal-title":"Circulation"},{"key":"10580_CR20","first-page":"e2633","volume":"25","author":"N Jafari","year":"2023","unstructured":"Jafari N et al (2023) Evaluating the effect of cancer stem cell on cardio-toxicity: molecular mechanism and future approach. Iran Red Crescent Med J 25:e2633","journal-title":"Iran Red Crescent Med J"},{"issue":"Suppl 2","key":"10580_CR21","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.33549\/physiolres.934345","volume":"68","author":"A Samakova","year":"2019","unstructured":"Samakova A et al (2019) The PI3k\/Akt pathway is associated with angiogenesis, oxidative stress and survival of mesenchymal stem cells in pathophysiologic condition in ischemia. Physiol Res 68(Suppl 2):S131\u2013S138","journal-title":"Physiol Res"},{"issue":"1","key":"10580_CR22","doi-asserted-by":"crossref","first-page":"4:3","DOI":"10.1186\/s13619-015-0017-8","volume":"4","author":"G Ozhan","year":"2015","unstructured":"Ozhan G, Weidinger G (2015) Wnt\/\u03b2-catenin signaling in heart regeneration. Cell Regeneration 4(1):4:3","journal-title":"Cell Regeneration"},{"issue":"4","key":"10580_CR23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1242\/dmm.006510","volume":"4","author":"O Aisagbonhi","year":"2011","unstructured":"Aisagbonhi O et al (2011) Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition. Dis Model Mech 4(4):469\u2013483","journal-title":"Dis Model Mech"},{"issue":"1","key":"10580_CR24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/imcb.1019","volume":"96","author":"L Huang","year":"2018","unstructured":"Huang L et al (2018) Beta-catenin promotes macrophage-mediated acute inflammatory response after myocardial infarction. Immunol Cell Biol 96(1):100\u2013113","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"10580_CR25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41401-018-0060-4","volume":"40","author":"W-B Fu","year":"2019","unstructured":"Fu W-B, Wang WE, Zeng C-Y (2019) Wnt signaling pathways in myocardial infarction and the therapeutic effects of Wnt pathway inhibitors. Acta Pharmacol Sin 40(1):9\u201312","journal-title":"Acta Pharmacol Sin"},{"key":"10580_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.yjmcc.2015.11.017","volume":"91","author":"KC Hermans","year":"2016","unstructured":"Hermans KC, Daskalopoulos EP, Blankesteijn WM (2016) The Janus face of myofibroblasts in the remodeling heart. J Mol Cell Cardiol 91:35\u201341","journal-title":"J Mol Cell Cardiol"},{"key":"10580_CR27","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s10753-021-01460-9","volume":"44","author":"X Wang","year":"2021","unstructured":"Wang X et al (2021) Adipose-derived mesenchymal stem cells-derived exosomes carry microRNA-671 to alleviate myocardial infarction through inactivating the TGFBR2\/Smad2 axis. Inflammation 44:1815\u20131830","journal-title":"Inflammation"},{"issue":"6","key":"10580_CR28","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1159\/000489683","volume":"46","author":"L Qian","year":"2018","unstructured":"Qian L et al (2018) Downregulation of S100A4 alleviates cardiac fibrosis via Wnt\/\u03b2-catenin pathway in mice. Cell Physiol Biochem 46(6):2551\u20132560","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"10580_CR29","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1096\/fj.201600502R","volume":"30","author":"D Bastakoty","year":"2016","unstructured":"Bastakoty D, Young PP (2016) Wnt\/\u03b2-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration. FASEB J 30(10):3271","journal-title":"FASEB J"},{"issue":"7","key":"10580_CR30","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1073\/pnas.1116136109","volume":"109","author":"A von Gise","year":"2012","unstructured":"von Gise A et al (2012) YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc Natl Acad Sci 109(7):2394\u20132399","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10580_CR31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCRESAHA.115.304457","volume":"116","author":"Z Lin","year":"2015","unstructured":"Lin Z et al (2015) Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. Circ Res 116(1):35\u201345","journal-title":"Circ Res"},{"issue":"8","key":"10580_CR32","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/molbev\/msr065","volume":"28","author":"D Hilman","year":"2011","unstructured":"Hilman D, Gat U (2011) The evolutionary history of YAP and the hippo\/YAP pathway. Mol Biol Evol 28(8):2403\u20132417","journal-title":"Mol Biol Evol"},{"issue":"9","key":"10580_CR33","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1161\/01.RES.0000265846.23485.7a","volume":"100","author":"M Odashima","year":"2007","unstructured":"Odashima M et al (2007) Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction. Circ Res 100(9):1344\u20131352","journal-title":"Circ Res"},{"issue":"11","key":"10580_CR34","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tibs.2017.09.003","volume":"42","author":"KC Lin","year":"2017","unstructured":"Lin KC, Park HW, Guan K-L (2017) Regulation of the Hippo pathway transcription factor TEAD. Trends Biochem Sci 42(11):862\u2013872","journal-title":"Trends Biochem Sci"},{"key":"10580_CR35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.yjmcc.2017.11.010","volume":"114","author":"Y Yang","year":"2018","unstructured":"Yang Y et al (2018) Understanding the role of mammalian sterile 20-like kinase 1 (MST1) in cardiovascular disorders. J Mol Cell Cardiol 114:141\u2013149","journal-title":"J Mol Cell Cardiol"},{"issue":"600","key":"10580_CR36","doi-asserted-by":"crossref","first-page":"eabd6892","DOI":"10.1126\/scitranslmed.abd6892","volume":"13","author":"S Liu","year":"2021","unstructured":"Liu S et al (2021) Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction. Sci Transl Med 13(600):eabd6892","journal-title":"Sci Transl Med"},{"issue":"16","key":"10580_CR37","first-page":"7120","volume":"23","author":"H-T Zeng","year":"2019","unstructured":"Zeng H-T et al (2019) Atorvastatin improves the cardiac function of rats after acute myocardial infarction through ERK1\/2 pathway. Eur Rev Med Pharmacol Sci 23(16):7120\u20137127","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10580_CR38","volume":"120","author":"S-N Li","year":"2019","unstructured":"Li S-N et al (2019) Danhong injection enhances angiogenesis after myocardial infarction by activating MiR-126\/ERK\/VEGF pathway. Biomed Pharmacother 120:109538","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10580_CR39","first-page":"1297","volume":"34","author":"G Qiao","year":"2020","unstructured":"Qiao G et al (2020) MiR-125b Improves acute myocardial infarction in rats by regulating P38\/Sirtl\/P53 signaling pathway. J Biol Regul Homeost Agents 34(4):1297\u20131306","journal-title":"J Biol Regul Homeost Agents"},{"key":"10580_CR40","volume":"173","author":"Z Zhang","year":"2024","unstructured":"Zhang Z et al (2024) Targeting MAPK-ERK\/JNK pathway: a potential intervention mechanism of myocardial fibrosis in heart failure. Biomed Pharmacother 173:116413","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10580_CR41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13619-020-00060-6","volume":"10","author":"H Li","year":"2021","unstructured":"Li H et al (2021) The roles and activation of endocardial Notch signaling in heart regeneration. Cell Regener 10(1):3","journal-title":"Cell Regener"},{"issue":"34","key":"10580_CR42","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1073\/pnas.1313192110","volume":"110","author":"M Xin","year":"2013","unstructured":"Xin M et al (2013) Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci USA 110(34):13839\u201313844","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10580_CR43","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3390\/biom10071024","volume":"10","author":"M Zheng","year":"2020","unstructured":"Zheng M et al (2020) The hippo pathway in cardiac regeneration and homeostasis: new perspectives for cell-free therapy in the injured heart. Biomolecules 10(7):1024","journal-title":"Biomolecules"},{"issue":"3","key":"10580_CR44","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13912","volume":"237","author":"VV Balatskyi","year":"2023","unstructured":"Balatskyi VV et al (2023) WNT\/\u03b2-catenin pathway is a key regulator of cardiac function and energetic metabolism. Acta Physiol 237(3):e13912","journal-title":"Acta Physiol"},{"issue":"3","key":"10580_CR45","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","volume":"122","author":"S Sciarretta","year":"2018","unstructured":"Sciarretta S et al (2018) New insights into the role of mTOR signaling in the cardiovascular system. Circ Res 122(3):489\u2013505","journal-title":"Circ Res"},{"issue":"3","key":"10580_CR46","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/biom10030404","volume":"10","author":"E Dronkers","year":"2020","unstructured":"Dronkers E et al (2020) Epicardial TGF\u03b2 and BMP signaling in cardiac regeneration: what lesson can we learn from the developing heart? Biomolecules 10(3):404","journal-title":"Biomolecules"},{"issue":"11","key":"10580_CR47","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/biom10111587","volume":"10","author":"M Bostan","year":"2020","unstructured":"Bostan M et al (2020) Post-myocardial infarction ventricular remodeling biomarkers-the key link between pathophysiology and clinic. Biomolecules 10(11):1587","journal-title":"Biomolecules"},{"key":"10580_CR48","first-page":"1","volume":"12","author":"VS Raberi","year":"2023","unstructured":"Raberi VS et al (2023) Emerging biomarkers of acute myocardial infarction, an overview of the newest MicroRNAs. Galen Med J 12:1","journal-title":"Galen Med J"},{"key":"10580_CR49","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101530","volume":"50","author":"N Salerno","year":"2022","unstructured":"Salerno N et al (2022) Myocardial regeneration protocols towards the routine clinical scenario: an unseemly path from bench to bedside. EClinicalMedicine 50:101530","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10580_CR50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5045\/br.2013.48.2.76","volume":"48","author":"W-S Kim","year":"2013","unstructured":"Kim W-S, Lee S, Yoon Y-S (2013) Cardiovascular repair with bone marrow-derived cells. Blood Res 48(2):76\u201386","journal-title":"Blood Res"},{"issue":"9","key":"10580_CR51","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4252\/wjsc.v13.i9.1231","volume":"13","author":"TH Kasai-Brunswick","year":"2021","unstructured":"Kasai-Brunswick TH, Carvalho AB, de Carvalho ACC (2021) Stem cell therapies in cardiac diseases: current status and future possibilities. World J Stem Cells 13(9):1231","journal-title":"World J Stem Cells"},{"key":"10580_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-017-0697-9","volume":"8","author":"C Miao","year":"2017","unstructured":"Miao C et al (2017) A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction. Stem Cell Res Ther 8:1\u20136","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10580_CR53","first-page":"588","volume":"36","author":"Y-H Fang","year":"2020","unstructured":"Fang Y-H et al (2020) Immunogenicity in stem cell therapy for cardiac regeneration. Acta Cardiologica Sinica 36(6):588","journal-title":"Acta Cardiologica Sinica"},{"issue":"1","key":"10580_CR54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13578-024-01211-x","volume":"14","author":"R Bryl","year":"2024","unstructured":"Bryl R et al (2024) Cardiac progenitor cell therapy: mechanisms of action. Cell Biosci 14(1):30","journal-title":"Cell Biosci"},{"issue":"2","key":"10580_CR55","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCHEARTFAILURE.114.001484","volume":"8","author":"H Kanazawa","year":"2015","unstructured":"Kanazawa H et al (2015) Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction. Circul Heart Fail 8(2):322\u2013332","journal-title":"Circul Heart Fail"},{"issue":"2","key":"10580_CR56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.RES.0000053618.86362.DF","volume":"92","author":"B Nadal-Ginard","year":"2003","unstructured":"Nadal-Ginard B et al (2003) Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 92(2):139\u2013150","journal-title":"Circ Res"},{"issue":"1","key":"10580_CR57","first-page":"8283648","volume":"2018","author":"N Witman","year":"2018","unstructured":"Witman N, Sahara M (2018) Cardiac progenitor cells in basic biology and regenerative medicine. Stem Cells Int 2018(1):8283648","journal-title":"Stem Cells Int"},{"issue":"9819","key":"10580_CR58","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","volume":"379","author":"RR Makkar","year":"2012","unstructured":"Makkar RR et al (2012) Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. The Lancet 379(9819):895\u2013904","journal-title":"The Lancet"},{"issue":"2","key":"10580_CR59","first-page":"186","volume":"10","author":"BC du Pr\u00e9","year":"2013","unstructured":"du Pr\u00e9 BC, Doevendans PA, van Laake LW (2013) Stem cells for cardiac repair: an introduction. J Geriatric Cardiol: JGC 10(2):186","journal-title":"J Geriatric Cardiol: JGC"},{"issue":"3","key":"10580_CR60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/CIRCULATIONAHA.119.045566","volume":"142","author":"L He","year":"2020","unstructured":"He L et al (2020) Heart regeneration by endogenous stem cells and cardiomyocyte proliferation: controversy, fallacy, and progress. Circulation 142(3):275\u2013291","journal-title":"Circulation"},{"issue":"5","key":"10580_CR61","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","volume":"12","author":"R Romagnuolo","year":"2019","unstructured":"Romagnuolo R et al (2019) Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias. Stem Cell Rep 12(5):967\u2013981","journal-title":"Stem Cell Rep"},{"key":"10580_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1471-y","volume":"11","author":"LC Liew","year":"2020","unstructured":"Liew LC, Ho BX, Soh B-S (2020) Mending a broken heart: current strategies and limitations of cell-based therapy. Stem Cell Res Ther 11:1\u201315","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10580_CR63","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/er.2008-0031","volume":"30","author":"B Lo","year":"2009","unstructured":"Lo B, Parham L (2009) Ethical issues in stem cell research. Endocr Rev 30(3):204\u2013213","journal-title":"Endocr Rev"},{"key":"10580_CR64","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-230X(08)00005-5","volume":"100","author":"B Blum","year":"2008","unstructured":"Blum B, Benvenisty N (2008) The tumorigenicity of human embryonic stem cells. Adv Cancer Res 100:133\u2013158","journal-title":"Adv Cancer Res"},{"issue":"35","key":"10580_CR65","doi-asserted-by":"crossref","first-page":"12991","DOI":"10.1073\/pnas.0805802105","volume":"105","author":"R-J Swijnenburg","year":"2008","unstructured":"Swijnenburg R-J et al (2008) Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci 105(35):12991\u201312996","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"10580_CR66","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt.4162","volume":"36","author":"Y-W Liu","year":"2018","unstructured":"Liu Y-W et al (2018) Human embryonic stem cell\u2013derived cardiomyocytes restore function in infarcted hearts of non-human primates. Nat Biotechnol 36(7):597\u2013605","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10580_CR67","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/stem.1331","volume":"31","author":"C Robertson","year":"2013","unstructured":"Robertson C, Tran DD, George SC (2013) Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells 31(5):829\u2013837","journal-title":"Stem Cells"},{"issue":"7","key":"10580_CR68","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.bbamcr.2015.10.014","volume":"1863","author":"C Denning","year":"2016","unstructured":"Denning C et al (2016) Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform. Biochimica et Biophysica Acta (BBA)-Mol Cell Res 1863(7):1728\u20131748","journal-title":"Biochimica et Biophysica Acta (BBA)-Mol Cell Res"},{"issue":"1","key":"10580_CR69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymthe.2021.10.015","volume":"30","author":"L Jiang","year":"2022","unstructured":"Jiang L et al (2022) CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy. Mol Ther 30(1):54\u201374","journal-title":"Mol Ther"},{"issue":"6530","key":"10580_CR70","doi-asserted-by":"crossref","first-page":"eabd0724","DOI":"10.1126\/science.abd0724","volume":"371","author":"CV Theodoris","year":"2021","unstructured":"Theodoris CV et al (2021) Network-based screen in iPSC-derived cells reveals therapeutic candidate for heart valve disease. Science 371(6530):eabd0724","journal-title":"Science"},{"issue":"7","key":"10580_CR71","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.hlc.2022.12.014","volume":"32","author":"H Ichimura","year":"2023","unstructured":"Ichimura H, Chino S, Shiba Y (2023) Cardiac regeneration using pluripotent stem cells and controlling immune responses. Heart Lung Circ 32(7):836\u2013843","journal-title":"Heart Lung Circ"},{"issue":"7336","key":"10580_CR72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature09805","volume":"471","author":"A Gore","year":"2011","unstructured":"Gore A et al (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature 471(7336):63\u201367","journal-title":"Nature"},{"issue":"7","key":"10580_CR73","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ymthe.2018.05.009","volume":"26","author":"L Bagno","year":"2018","unstructured":"Bagno L et al (2018) Mesenchymal stem cell-based therapy for cardiovascular disease: progress and challenges. Mol Ther 26(7):1610\u20131623","journal-title":"Mol Ther"},{"issue":"25","key":"10580_CR74","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1161\/CIRCULATIONAHA.118.038361","volume":"139","author":"S Huang","year":"2019","unstructured":"Huang S et al (2019) Loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation 139(25):2857\u20132876","journal-title":"Circulation"},{"issue":"5","key":"10580_CR75","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41419-020-2542-9","volume":"11","author":"Y Guo","year":"2020","unstructured":"Guo Y et al (2020) The therapeutic potential of mesenchymal stem cells for cardiovascular diseases. Cell Death Dis 11(5):349","journal-title":"Cell Death Dis"},{"key":"10580_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2023.12.009","volume":"188","author":"W Yan","year":"2024","unstructured":"Yan W et al (2024) Stem cell-based therapy in cardiac repair after myocardial infarction: Promise, challenges, and future directions. J Mol Cell Cardiol 188:1\u201314","journal-title":"J Mol Cell Cardiol"},{"key":"10580_CR77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00795-017-0156-9","volume":"50","author":"BR Adhikari","year":"2017","unstructured":"Adhikari BR et al (2017) Immunohistochemical evaluation of Klotho and DNA methyltransferase 3a in oral squamous cell carcinomas. Med Mol Morphol 50:155\u2013160","journal-title":"Med Mol Morphol"},{"key":"10580_CR78","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s13287-021-02451-1","volume":"12","author":"D Chang","year":"2021","unstructured":"Chang D et al (2021) Application of mesenchymal stem cell sheet to treatment of ischemic heart. Stem Cell Res Therapy 12:384","journal-title":"Stem Cell Res Therapy"},{"issue":"3","key":"10580_CR79","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1139\/cjpp-2023-0202","volume":"102","author":"JK Gill","year":"2024","unstructured":"Gill JK et al (2024) Stem cell therapy for cardiac regeneration: past, present, and future. Can J Physiol Pharmacol 102(3):161\u2013179","journal-title":"Can J Physiol Pharmacol"},{"issue":"10","key":"10580_CR80","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"J Bartolucci","year":"2017","unstructured":"Bartolucci J et al (2017) Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: a phase 1\/2 randomized controlled trial (RIMECARD trial [randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy]). Circ Res 121(10):1192\u20131204","journal-title":"Circ Res"},{"issue":"2","key":"10580_CR81","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.118.313251","volume":"123","author":"M Wysoczynki","year":"2018","unstructured":"Wysoczynki M, Khan A, Bolli R (2018) New paradigms in cell therapy: repeated dosing, intravenous delivery, immunomodulatory actions, and new cell types. Circ Res 123(2):138\u2013158","journal-title":"Circ Res"},{"issue":"11","key":"10580_CR82","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1089\/hum.2017.129","volume":"28","author":"J L\u00e4hteenvuo","year":"2017","unstructured":"L\u00e4hteenvuo J, Yl\u00e4-Herttuala S (2017) Advances and challenges in cardiovascular gene therapy. Hum Gene Ther 28(11):1024\u20131032","journal-title":"Hum Gene Ther"},{"key":"10580_CR83","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fbioe.2020.00455","volume":"8","author":"M Mazzola","year":"2020","unstructured":"Mazzola M, Di Pasquale E (2020) Toward cardiac regeneration: combination of pluripotent stem cell-based therapies and bioengineering strategies. Front in Bioeng Biotechnol 8:455","journal-title":"Front in Bioeng Biotechnol"},{"issue":"3","key":"10580_CR84","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41587-019-0042-1","volume":"37","author":"KR Chien","year":"2019","unstructured":"Chien KR et al (2019) Regenerating the field of cardiovascular cell therapy. Nat Biotechnol 37(3):232\u2013237","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10580_CR85","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.3390\/ijms25073778","volume":"25","author":"I-T Tsai","year":"2024","unstructured":"Tsai I-T, Sun C-K (2024) Stem cell therapy against ischemic heart disease. Int J Mol Sci 25(7):3778","journal-title":"Int J Mol Sci"},{"key":"10580_CR86","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.carrev.2020.06.031","volume":"22","author":"AN Raval","year":"2021","unstructured":"Raval AN, Pepine CJ (2021) Clinical safety profile of transendocardial catheter injection systems: a plea for uniform reporting. Cardiovasc Revasc Med 22:100\u2013108","journal-title":"Cardiovasc Revasc Med"},{"key":"10580_CR87","unstructured":"Silva GV, Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Assad JA, Vaughn WK, Mesquita CT, Bel\u00e9m L, Carvalho AC (2004) Catheter\u2013based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation. Tex Heart Inst J 31(3):214"},{"issue":"2","key":"10580_CR88","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/ehf2.15124","volume":"12","author":"J Roncalli","year":"2025","unstructured":"Roncalli J et al (2025) Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: design of the EXCELLENT trial. ESC Heart Fail 12(2):1455\u20131463","journal-title":"ESC Heart Fail"},{"key":"10580_CR89","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ahj.2018.03.016","volume":"201","author":"AN Raval","year":"2018","unstructured":"Raval AN et al (2018) The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post\u2013myocardial infarction heart failure: trial rationale and study design. Am Heart J 201:141\u2013148","journal-title":"Am Heart J"},{"issue":"1","key":"10580_CR90","doi-asserted-by":"crossref","first-page":"hoae074","DOI":"10.1093\/hropen\/hoae074","volume":"2025","author":"A Van Der Kelen","year":"2025","unstructured":"Van Der Kelen A et al (2025) The interplay between mitochondrial DNA genotypes, female infertility, ovarian response, and mutagenesis in oocytes. Hum Reprod Open 2025(1):hoae074","journal-title":"Hum Reprod Open"},{"key":"10580_CR91","volume":"7","author":"X Mei","year":"2020","unstructured":"Mei X, Cheng K (2020) Recent development in therapeutic cardiac patches. Front Cardiovasc Med 7:610364","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"10580_CR92","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41551-017-0157-y","volume":"1","author":"LL Wang","year":"2017","unstructured":"Wang LL et al (2017) Sustained miRNA delivery from an injectable hydrogel promotes cardiomyocyte proliferation and functional regeneration after ischaemic injury. Nat Biomed Eng 1(12):983\u2013992","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"10580_CR93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41536-021-00140-4","volume":"6","author":"MF Tenreiro","year":"2021","unstructured":"Tenreiro MF et al (2021) Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering. NPJ Regen Med 6(1):30","journal-title":"NPJ Regen Med"},{"key":"10580_CR94","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.lfs.2016.04.011","volume":"153","author":"C Dall","year":"2016","unstructured":"Dall C et al (2016) Oxygen cycling to improve survival of stem cells for myocardial repair: a review. Life Sci 153:124\u2013131","journal-title":"Life Sci"},{"issue":"2","key":"10580_CR95","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jtcvs.2017.03.141","volume":"154","author":"L Li","year":"2017","unstructured":"Li L et al (2017) Hypoxia modulates cell migration and proliferation in placenta-derived mesenchymal stem cells. J Thoracic Cardiovasc Surg 154(2):543\u2013552","journal-title":"J Thoracic Cardiovasc Surg"},{"issue":"6","key":"10580_CR96","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s12192-016-0733-1","volume":"21","author":"DS Kim","year":"2016","unstructured":"Kim DS et al (2016) Effect of low oxygen tension on the biological characteristics of human bone marrow mesenchymal stem cells. Cell Stress Chaperones 21(6):1089\u20131099","journal-title":"Cell Stress Chaperones"},{"issue":"1","key":"10580_CR97","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4252\/wjsc.v9.i1.9","volume":"9","author":"S Der Sarkissian","year":"2017","unstructured":"Der Sarkissian S, L\u00e9vesque T, Noiseux N (2017) Optimizing stem cells for cardiac repair: current status and new frontiers in regenerative cardiology. World J Stem Cells 9(1):9","journal-title":"World J Stem Cells"},{"issue":"2","key":"10580_CR98","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12248","volume":"35","author":"I Khan","year":"2017","unstructured":"Khan I et al (2017) Epac-Rap1-activated mesenchymal stem cells improve cardiac function in rat model of myocardial infarction. Cardiovasc Ther 35(2):e12248","journal-title":"Cardiovasc Ther"},{"issue":"5","key":"10580_CR99","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/term.2117","volume":"11","author":"J Lewandowski","year":"2017","unstructured":"Lewandowski J, Kolanowski TJ, Kurpisz M (2017) Techniques for the induction of human pluripotent stem cell differentiation towards cardiomyocytes. J Tissue Eng Regen Med 11(5):1658\u20131674","journal-title":"J Tissue Eng Regen Med"},{"issue":"1","key":"10580_CR100","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13287-024-03831-z","volume":"15","author":"H Zhou","year":"2024","unstructured":"Zhou H et al (2024) Genome-scale CRISPR-Cas9 screening in stem cells: theories, applications and challenges. Stem Cell Res Ther 15(1):218","journal-title":"Stem Cell Res Ther"},{"key":"10580_CR101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ddtec.2018.06.002","volume":"28","author":"E Christidi","year":"2018","unstructured":"Christidi E, Huang HM, Brunham LR (2018) CRISPR\/Cas9-mediated genome editing in human stem cell-derived cardiomyocytes: applications for cardiovascular disease modelling and cardiotoxicity screening. Drug Discov Today Technol 28:13\u201321","journal-title":"Drug Discov Today Technol"},{"issue":"1","key":"10580_CR102","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1038\/s41598-023-31286-4","volume":"13","author":"Y Schary","year":"2023","unstructured":"Schary Y et al (2023) CRISPR-Cas9 editing of TLR4 to improve the outcome of cardiac cell therapy. Sci Rep 13(1):4481","journal-title":"Sci Rep"},{"issue":"4","key":"10580_CR103","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/cells12040520","volume":"12","author":"JM In\u00e1cio","year":"2023","unstructured":"In\u00e1cio JM et al (2023) Gene-edited human-induced pluripotent stem cell lines to elucidate DAND5 function throughout cardiac differentiation. Cells 12(4):520","journal-title":"Cells"},{"key":"10580_CR104","unstructured":"Graham N (2023) An investigation of the roles of GATA4 and its target genes in cardiac differentiation of iPS Cells, Cardiff University."},{"key":"10580_CR105","doi-asserted-by":"crossref","first-page":"10817","DOI":"10.3389\/ti.2022.10817","volume":"35","author":"SD Sackett","year":"2022","unstructured":"Sackett SD et al (2022) Genetic engineering of immune evasive stem cell-derived islets. Transpl Int 35:10817","journal-title":"Transpl Int"},{"issue":"21","key":"10580_CR106","doi-asserted-by":"crossref","first-page":"11394","DOI":"10.3390\/ijms222111394","volume":"22","author":"S Yamada","year":"2021","unstructured":"Yamada S et al (2021) Mass customized outlook for regenerative heart failure care. Int J Mol Sci 22(21):11394","journal-title":"Int J Mol Sci"},{"issue":"22","key":"10580_CR107","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"308","author":"JM Hare","year":"2012","unstructured":"Hare JM et al (2012) Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 308(22):2369\u20132379","journal-title":"JAMA"},{"issue":"1","key":"10580_CR108","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","volume":"311","author":"AW Heldman","year":"2014","unstructured":"Heldman AW et al (2014) Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA 311(1):62\u201373","journal-title":"JAMA"},{"issue":"4","key":"10580_CR109","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ejhf.2178","volume":"23","author":"R Bolli","year":"2021","unstructured":"Bolli R et al (2021) A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial. Eur J Heart Fail 23(4):661\u2013674","journal-title":"Eur J Heart Fail"},{"issue":"27","key":"10580_CR110","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","volume":"36","author":"AB Mathiasen","year":"2015","unstructured":"Mathiasen AB et al (2015) Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). Eur Heart J 36(27):1744\u20131753","journal-title":"Eur Heart J"},{"issue":"11","key":"10580_CR111","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/CIRCRESAHA.117.311827","volume":"121","author":"V Florea","year":"2017","unstructured":"Florea V et al (2017) Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (the TRIDENT study). Circ Res 121(11):1279\u20131290","journal-title":"Circ Res"},{"issue":"6","key":"10580_CR112","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1002\/ehf2.13031","volume":"7","author":"J Bartunek","year":"2020","unstructured":"Bartunek J et al (2020) Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomes. ESC Heart Failure 7(6):3345\u20133354","journal-title":"ESC Heart Failure"},{"key":"10580_CR113","unstructured":"Perin EC, et al. (2021) Randomized trial of targeted transendocardial delivery of mesenchymal precursor cells in high-risk chronic heart failure patients with reduced ejection fraction, Circulation, In: LIPPINCOTT WILLIAMS & WILKINS TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA"},{"issue":"4","key":"10580_CR114","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","volume":"71","author":"P Menasch\u00e9","year":"2018","unstructured":"Menasch\u00e9 P et al (2018) Transplantation of human embryonic stem cell\u2013derived cardiovascular progenitors for severe ischemic left ventricular dysfunction. J Am Coll Cardiol 71(4):429\u2013438","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10580_CR115","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cvr\/cvab135","volume":"118","author":"R Bolli","year":"2022","unstructured":"Bolli R et al (2022) Cell therapy in patients with heart failure: a comprehensive review and emerging concepts. Cardiovasc Res 118(4):951\u2013976","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10580_CR116","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2217\/fon.13.22","volume":"9","author":"T Nouspikel","year":"2013","unstructured":"Nouspikel T (2013) Genetic instability in human embryonic stem cells: prospects and caveats. Future Oncol 9(6):867\u2013877","journal-title":"Future Oncol"},{"issue":"9","key":"10580_CR117","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2022.11.061","volume":"81","author":"EC Perin","year":"2023","unstructured":"Perin EC et al (2023) Randomized trial of targeted transendocardial mesenchymal precursor cell therapy in patients with heart failure. J Am Coll Cardiol 81(9):849\u2013863","journal-title":"J Am Coll Cardiol"},{"key":"10580_CR118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12015-021-10310-y","volume":"18","author":"JY Kim","year":"2022","unstructured":"Kim JY et al (2022) Review of the current trends in clinical trials involving induced pluripotent stem cells. Stem Cell Rev Rep 18:1\u201313","journal-title":"Stem Cell Rev Rep"},{"issue":"10","key":"10580_CR119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111064","volume":"9","author":"T Kawamura","year":"2014","unstructured":"Kawamura T et al (2014) N-glycans: phenotypic homology and structural differences between myocardial cells and induced pluripotent stem cell-derived cardiomyocytes. PLoS ONE 9(10):e111064","journal-title":"PLoS ONE"},{"issue":"11","key":"10580_CR120","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","volume":"376","author":"M Mandai","year":"2017","unstructured":"Mandai M et al (2017) Autologous induced stem-cell\u2013derived retinal cells for macular degeneration. N Engl J Med 376(11):1038\u20131046","journal-title":"N Engl J Med"},{"issue":"11","key":"10580_CR121","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.5966\/sctm.2015-0029","volume":"4","author":"T Kawamura","year":"2015","unstructured":"Kawamura T et al (2015) Structural changes in N-glycans on induced pluripotent stem cells differentiating toward cardiomyocytes. Stem Cells Transl Med 4(11):1258\u20131264","journal-title":"Stem Cells Transl Med"},{"issue":"13","key":"10580_CR122","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008649","volume":"10","author":"K Domae","year":"2021","unstructured":"Domae K et al (2021) Clinical outcomes of autologous stem cell-patch implantation for patients with heart failure with nonischemic dilated cardiomyopathy. J Am Heart Assoc 10(13):e008649","journal-title":"J Am Heart Assoc"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10580-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:37:24Z","timestamp":1766853444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10580-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10580"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10580-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known conflict of interests\/competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"511"}}